Javier Cortés
Hospital Universitario de Torrejón
Javier Cortés Granados is a former Mexican professional footballer who played as a midfielder. He is an Olympic gold medalist.
Read biography ↓Biography, research & contributions
Javier Cortés Granados is a former Mexican professional footballer who played as a midfielder. He is an Olympic gold medalist.
Affiliation
Hospital Universitario de Torrejón
Top Publications
- Pembrolizumab for Early Triple-Negative Breast Cancer (2020) - 3,331 citations
- Breast cancer (2019) - 3,100 citations
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer (2011) - 2,573 citations
- Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer (2015) - 2,193 citations
- Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer (2019) - 2,041 citations
At a glance
- Full name
- Javier Cortés
- ORCID
- 0000-0001-7623-1583
- OpenAlex ID
- https://openalex.org/A5051629490
Research interests
- Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Gastric Cancer Management and Outcomes
Research topics
Education
Not yet documented in this profile.
Selected research & further reading
A curated reading list, not a ranking by citation count. References use DOI metadata, matching public scholarly records or authoritative lecture sources.
See the source-linked reading and original works in the research guide above.
Citation & publication trends
Annual counts are not yet available from a verified author record. Explore the research guide above for the work itself; publication and citation totals depend on database coverage.
Source: OpenAlex · Retrieved 2026-10-07. Metrics are database-specific and are not a scientific ranking.
Most-cited linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Pembrolizumab for Early Triple-Negative Breast Cancer ↗2020 · New England Journal of Medicine3,331OpenAlex citations
- Breast cancer ↗2019 · Nature Reviews Disease Primers3,100OpenAlex citations
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer ↗2011 · New England Journal of Medicine2,573OpenAlex citations
- Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer ↗2015 · New England Journal of Medicine2,193OpenAlex citations
- Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer ↗2019 · New England Journal of Medicine2,041OpenAlex citations
Recent linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Pembrolizumab for Early Triple-Negative Breast Cancer ↗2020 · New England Journal of Medicine
- Breast cancer ↗2019 · Nature Reviews Disease Primers
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer ↗2011 · New England Journal of Medicine
- Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer ↗2015 · New England Journal of Medicine
- Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer ↗2019 · New England Journal of Medicine
Journals published in
No verified record links added yet.
Related publishers
No verified record links added yet.
Institutions
Current verified institution
No verified record links added yet.
Previous institutions
No verified record links added yet.
Awards & honors
Not yet documented in this profile.
Career timeline
Not yet documented in this profile.
Co-authors
No verified record links added yet.
Education & career institution links
No verified record links added yet.
Claim & manage this profile
Are you this researcher? Sign in, provide identity evidence, and request administrator approval. Editing becomes available only after approval.
Sign in to claim this profileSources & data information
Editorial review: 2026-10-07 · Last data update: 2026-10-07 21:33:05
Unknown values are left blank. Linked publications may be a subset of total works. Identity verification, data retrieval and profile ownership are separate checks.